Research and Development Centers


Xenetic (London, Great Britain) is a leading biopharmaceutical company operating from the UK that develops high-value, differentiated pharmaceutical products in the fields of protein drugs, vaccines and anti-cancer drugs.

Xenetic operate out of laboratory and office space at the London Bioscience Innovation Centre (LBIC), part of the Royal Veterinary College, London. 

The laboratories of Lipoxen are dedicated to biochemical research and are equipped with multiple ÄKTA chromatography systems, HPLC systems, freeze and spray dryers, particle size analyser, plus all usual basic lab equipment. Xenetic has received 9 international patents for its innovations.


SymbioTec GmbH (Saarbrücken, Germany) is a German company working to develop next generation medicines for the treatment of cancer and infectious diseases. The company holds 20 international patents.

Symbiotec has a state-of-the-art biotech laboratory affiliated with HSCI in Saarbrücken equipped for proteomics, cell and molecular biology as well as biotechnology.

SymbioTec GmbH was founded by Drs. Volker Rusch and Michael Zeppezauer and started its operative business in 1999 in at Starterzentrum (a start-up centre) of the University of the Saarland. In 2001 the company moved to Science Park Saar 1 at the campus of the Saarland University. 

HSCI Laboratories

The Human Stem Cells Institute (Moscow, Russia), one of the leading biotech companies of Russia, is engaged in development of medicines and cell- and gene-based technologies with high-promising medical applications. The laboratories of HSCI are equipped with the very latest for cell processing and biotech research at the molecular level. The research potential of the laboratories is focused on development of methods for identifying and exploratory study of various types of cells, generation of induced pluripotent stem cells, creation of specific gene constructs and the study of their bioactivity. Scientists of the Institute are developing innovations for application in regenerative medicine. To date three innovations of the laboratories have been patented.